Nonin Medical has announced a partnership with IDEAL Life, a Toronto-based provider of remote health management solutions.
The results of a randomized controlled trial show that smokers visiting the emergency department (ED) are more than twice as likely to quit if counseling, nicotine replacement therapy, and relevant referrals are provided during the visit.
The FDA approved the first needle-free, patient-controlled, preprogrammed fentanyl delivery system for management of acute postoperative pain in adults.
In a study from Denmark, victims of cardiac arrest who got cardiopulmonary resuscitation (CPR) from a bystander were 38% more likely to eventually return to work.
The Sentrian Remote Patient Intelligence platform uses biosensors to monitor patients remotely, but the company uses machine learning to customize the alert parameters for each patient.
The federal government has authorized an additional $330 million in emergency funds to handle the quickly spreading avian influenza outbreak in US poultry.
Corbus, a small biopharmaceutical company, received $5 million from the Cystic Fibrosis Foundation last month to develop the drug, Resunab.
As the time from collapse to CPR was delayed, there was an increase in the proportion of asystole, and decreases in those of pVT/VF and PEA.
The Tdap vaccine given to preteens loses a large measure of effectiveness within a few years, according to a study published online May 4 in Pediatrics.
A new study implicates a specific mitochondrial protein and pathway in the development of COPD from exposure to cigarette smoke.
The resource will provide quality assured, standardized asthma training, specifically designed for anyone working with children or young people.
Researchers at the University of Alabama at Birmingham have obtained an $11 million grant from the Department of Defense to study the role of beta blockers in patients with COPD.
The School of Public Health at Georgia State University has named five major municipalities in China that will partner with the school on policies and programs to reduce smoking.
Ephraim McDowell MedSource in Kentucky has been named a quality respiratory care under the Quality Respiratory Care Recognition program, which began in 2003.
GlaxoSmithKline (GSK) and Theravance, Inc, have announced that Breo Ellipta has been approved by the Food and Drug Administration (FDA) for the once-daily treatment of asthma in patients ages 18 years and older.
The findings of a Veterans Affairs study shows the high dose version of a flu vaccine may be more effective than a standard vaccine for those 85 years or older.
Persons with COPD and high blood eosinophil can significantly benefit from the use of inhaled corticosteroids, according to a recent study.
A team of neuroscientists have identified circuitry in the brain responsible for the increased anxiety often experienced during withdrawal from nicotine addiction.
Current bubble CPAP products available on the market enable respiratory therapists to deliver vital care to newborns and infants.
Novartis has plans to roll out the Volari COPD app to 10 countries this year. The app intends to improve patient-physician communication.